Bajaj Healthcare Ltd

Bajaj Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bajaj Healthcare Ltd

₹ 530 -0.33%
10 Jun - close price
bajajhealth.com BSE: 539872 NSE: BAJAJHCARE
About

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations[1]

Key Points

Business Overview:[1][2][3]
BHL is focused on development, supply, manufacturing of Amino Acids, Nutritional Supplements and Active Pharma Ingredients for Pharmaceutical, Nutraceuticals and Food industries. It manufactures active pharmaceutical ingredients and formulations in the form of tablets, capsules, powder, etc. for ~550+ clients, exporting bulk drugs to ~62+ countries in Europe, USA, Africa, Australia, etc.

Website BSE NSE
  • Market Cap ₹ 1,674 Cr.
  • Current Price ₹ 530
  • High / Low ₹ 745 / 296
  • Stock P/E 39.0
  • Book Value ₹ 148
  • Dividend Yield 0.19 %
  • ROCE 11.4 %
  • ROE 11.5 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Stock is trading at 3.59 times its book value
  • The company has delivered a poor sales growth of 5.76% over past five years.
  • Company has a low return on equity of 4.45% over last 3 years.
  • Dividend payout has been low at 3.71% of profits over last 3 years
  • Company has high debtors of 169 days.
  • Promoter holding has decreased over last 3 years: -8.07%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
164 195 133 154 130 101 109 134 132 133 123 154
139 161 102 132 108 82 89 118 108 109 101 143
Operating Profit 24 34 30 22 22 19 20 16 24 25 22 12
OPM % 15% 18% 23% 14% 17% 19% 18% 12% 19% 18% 18% 8%
-2 -5 -6 -7 -55 -7 -7 -36 -0 4 -1 13
Interest 3 4 5 6 9 8 7 6 8 8 6 6
Depreciation 4 4 4 5 6 7 7 7 7 7 7 8
Profit before tax 16 22 15 5 -48 -3 -1 -33 9 14 8 11
Tax % 26% 26% 26% 21% -0% 4% 58% -10% 23% 30% -39% 1%
12 16 11 4 -48 -3 -2 -30 7 9 12 11
EPS in Rs 4.36 5.93 4.00 1.30 -17.47 -1.25 -0.80 -10.84 2.58 3.00 3.71 3.54
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
205 218 223 231 327 370 410 657 680 646 473 543
186 189 193 200 288 327 362 521 561 534 397 460
Operating Profit 19 29 30 31 39 43 48 136 119 112 76 82
OPM % 9% 13% 14% 13% 12% 12% 12% 21% 17% 17% 16% 15%
0 0 0 2 2 1 7 7 1 -19 -105 16
Interest 7 8 8 8 8 8 7 8 13 18 30 28
Depreciation 9 9 9 11 11 11 12 16 18 17 28 28
Profit before tax 3 12 14 14 23 24 36 119 90 58 -86 43
Tax % 40% 37% 39% 43% 33% 33% 30% 30% 20% 25% -3% 7%
2 8 8 8 15 16 25 83 71 43 -84 40
EPS in Rs 2.19 8.34 3.04 2.83 5.50 5.91 9.14 30.11 25.87 15.59 -30.36 12.51
Dividend Payout % 0% 0% 0% 0% 5% 0% 0% 5% 6% 6% -3% 8%
Compounded Sales Growth
10 Years: 10%
5 Years: 6%
3 Years: -7%
TTM: 15%
Compounded Profit Growth
10 Years: 19%
5 Years: 11%
3 Years: -16%
TTM: 209%
Stock Price CAGR
10 Years: %
5 Years: 33%
3 Years: 20%
1 Year: 78%
Return on Equity
10 Years: 13%
5 Years: 13%
3 Years: 4%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 2 2 7 7 7 7 14 14 14 14 14 16
Reserves 28 78 82 92 107 122 164 245 315 354 265 450
72 70 81 75 87 81 91 181 257 415 333 223
43 38 39 45 68 57 74 86 136 115 154 144
Total Liabilities 145 189 209 219 268 267 343 526 721 898 765 833
56 108 130 128 127 128 162 208 270 366 253 238
CWIP 3 1 1 0 2 1 5 57 52 22 7 3
Investments 0 0 0 0 0 0 5 0 0 0 0 0
87 79 78 91 140 137 170 260 399 510 506 591
Total Assets 145 189 209 219 268 267 343 526 721 898 765 833

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
17 28 25 22 17 25 21 44 1 -22 92 22
-9 -17 -31 -8 -12 -13 -28 -109 -75 -93 -11 -15
-8 -11 5 -13 2 -13 3 75 62 131 -97 -6
Net Cash Flow 1 -0 -0 0 7 -0 -4 10 -12 16 -16 0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 98 86 70 83 90 77 88 55 99 110 139 169
Inventory Days 51 50 56 45 57 45 54 94 143 199 206 206
Days Payable 68 63 46 51 74 45 80 67 94 81 128 122
Cash Conversion Cycle 81 73 80 78 73 77 62 82 148 228 217 254
Working Capital Days 62 52 52 58 61 66 76 90 142 208 226 230
ROCE % 10% 16% 13% 13% 16% 16% 18% 36% 20% 14% 8% 11%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
67.30% 67.30% 67.42% 67.49% 67.49% 67.69% 67.73% 67.74% 67.74% 59.19% 59.19% 59.19%
0.32% 0.09% 0.94% 0.78% 0.69% 0.66% 0.74% 0.53% 0.00% 1.07% 1.01% 1.05%
0.00% 0.00% 0.34% 0.34% 0.34% 0.43% 0.48% 0.43% 0.00% 1.97% 2.36% 2.52%
32.38% 32.62% 31.30% 31.38% 31.48% 31.22% 31.06% 31.31% 32.27% 37.77% 37.45% 37.25%
No. of Shareholders 30,90929,76926,93026,03727,32228,00829,62632,71232,39731,99532,67235,710

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Jun 2022
    Transcript
    Notes
    PPT
  • Aug 2020
    Transcript
    Notes
    PPT